Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1961 May;40(5):884–893. doi: 10.1172/JCI104323

EFFECTS OF TRIPARANOL (MER-29) ON CHOLESTEROL BIOSYNTHESIS AND ON BLOOD STEROL LEVELS IN MAN*

Daniel Steinberg 1, Joel Avigan 1, Eugene B Feigelson 1
PMCID: PMC290801  PMID: 16695861

Full text

PDF
884

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ABEL L. L., LEVY B. B., BRODIE B. B., KENDALL F. E. A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity. J Biol Chem. 1952 Mar;195(1):357–366. [PubMed] [Google Scholar]
  2. AVIGAN J., STEINBERG D., THOMPSON M. J., MOSETTIG E. Mechanism of action of MER-29, an inhibitor of cholesterol biosynthesis. Biochem Biophys Res Commun. 1960 Jan;2:63–65. doi: 10.1016/0006-291x(60)90266-7. [DOI] [PubMed] [Google Scholar]
  3. AVIGAN J., STEINBERG D., THOMPSON M. J., MOSETTIG E. The mechanism of action of MER-29. Prog Cardiovasc Dis. 1960 May;2:525–530. doi: 10.1016/s0033-0620(60)80024-2. [DOI] [PubMed] [Google Scholar]
  4. AVIGAN J., STEINBERG D., VROMAN H. E., THOMPSON M. J., MOSETTIG E. Studies of cholesterol biosynthesis. I. The identification of desmosterol in serum and tissues of animals and man treated with MER-29. J Biol Chem. 1960 Nov;235:3123–3126. [PubMed] [Google Scholar]
  5. BLOHM T. R., KARIYA T., LAUGHLIN M. W. Effects of MER-29, a cholesterol synthesis inhibitor, on mammalian tissue lipides. Arch Biochem Biophys. 1959 Nov;85:250–263. doi: 10.1016/0003-9861(59)90468-0. [DOI] [PubMed] [Google Scholar]
  6. BLOHM T. R., MACKENZIE R. D. Specific inhibition of cholesterol biosynthesis by a synthetic compound (MER-29). Arch Biochem Biophys. 1959 Nov;85:245–249. doi: 10.1016/0003-9861(59)90467-9. [DOI] [PubMed] [Google Scholar]
  7. BOYER P. A., Jr, LOWE J. T., GARDIER R. W., RALSTON J. D. Effect of a practical dietary regimen on serum cholesterol level. J Am Med Assoc. 1959 May 16;170(3):257–261. doi: 10.1001/jama.1959.03010030001001. [DOI] [PubMed] [Google Scholar]
  8. BROWN H. B., PAGE I. H. Lowering blood lipid levels by changing food patterns. J Am Med Assoc. 1958 Dec 13;168(15):1989–1995. doi: 10.1001/jama.1958.03000150031008. [DOI] [PubMed] [Google Scholar]
  9. CURRAN G. L. A rational approach to the treatment of atherosclerosis. Am Pract Dig Treat. 1956 Sep;7(9):1412–1417. [PubMed] [Google Scholar]
  10. CURRAN G. L., AZARNOFF D. L., BOLINGER R. E. Effect of cholesterol synthesis inhibition in normocholesteremic young men. J Clin Invest. 1959 Jul;38(7):1251–1261. doi: 10.1172/JCI103900. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. ECKLES N. E., TAYLOR C. B., CAMPBELL D. J., GOULD R. G. The origin of plasma cholesterol and the rates of equilibration of liver, plasma, and erythrocyte cholesterol. J Lab Clin Med. 1955 Sep;46(3):359–371. [PubMed] [Google Scholar]
  12. FREDRICKSON D. S., STEINBERG D. Failure of alpha-phenylbutyrate and beta-phenylvalerate in treatment of hypercholesterolemia. Circulation. 1957 Mar;15(3):391–396. doi: 10.1161/01.cir.15.3.391. [DOI] [PubMed] [Google Scholar]
  13. FREDRICKSON D. S., STEINBERG D. Inhibitors of cholesterol biosynthesis and the problem of hypercholesterolemia. Ann N Y Acad Sci. 1956 Nov 16;64(4):579–589. doi: 10.1111/j.1749-6632.1956.tb36832.x. [DOI] [PubMed] [Google Scholar]
  14. HELLMAN L., ROSENFELD R. S., EIDINOFF M. L., FUKUSHIMA D. K., GALLAGHER T. F., WANG C. I., ADLERSBERG D. Isotopic studies of plasma cholesterol of endogenous and exogenous origins. J Clin Invest. 1955 Jan;34(1):48–60. doi: 10.1172/JCI103062. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. HOLLANDER W., CHOBANIAN A. V., WILKINS R. W. The effects of triparanol (MER-29) in subjects with and without coronary artery disease. JAMA. 1960 Sep 3;174:5–12. doi: 10.1001/jama.1960.03030010007002. [DOI] [PubMed] [Google Scholar]
  16. IDLER D. R., BAUMANN C. A. Skin sterols. II. Isolation of delta 7-cholesterol. J Biol Chem. 1952 Apr;195(2):623–628. [PubMed] [Google Scholar]
  17. NICHOLS C. W., Jr, LINDSAY S., CHAIKOFF I. L. Production of arteriosclerosis in birds by the prolonged feeding of dihydrocholesterol. Proc Soc Exp Biol Med. 1955 Aug;89(4):609–613. doi: 10.3181/00379727-89-21891. [DOI] [PubMed] [Google Scholar]
  18. OAKS W., LISAN P., MOYER J. M. Inhibition of cholesterol synthesis with the use of Mer-29. Arch Intern Med. 1959 Oct;104:527–531. doi: 10.1001/archinte.1959.00270100013003. [DOI] [PubMed] [Google Scholar]
  19. PARSONS W. B., Jr, FLINN J. H. Reduction of serum cholesterol levels and beta-lipoprotein cholesterol levels by nicotinic acid. AMA Arch Intern Med. 1959 May;103(5):783–790. doi: 10.1001/archinte.1959.00270050105016. [DOI] [PubMed] [Google Scholar]
  20. STEINBERG D., AVIGAN J., FEIGELSON E. B. Identification of 24-dehydrocholesterol in the serum of patients treated with MER-29. Prog Cardiovasc Dis. 1960 May;2:586–592. doi: 10.1016/s0033-0620(60)80038-2. [DOI] [PubMed] [Google Scholar]
  21. STEINBERG D., FREDRICKSON D. S., AVIGAN J. Effects of 4-cholestenone in animals and in man. Proc Soc Exp Biol Med. 1958 Apr;97(4):784–790. doi: 10.3181/00379727-97-23880. [DOI] [PubMed] [Google Scholar]
  22. STEINBERG D., FREDRICKSON D. S. Inhibition of lipid synthesis by alpha-phenyl-N-butyrate and related compounds. Proc Soc Exp Biol Med. 1955 Oct;90(1):232–236. doi: 10.3181/00379727-90-21992. [DOI] [PubMed] [Google Scholar]
  23. TOMKINS G. M., NICHOLS C. W., Jr, CHAPMAN D. D., HOTTA S., CHAIKOFF I. L. [Use of delta 4-cholestenone to reduce the level of serum cholesterol in man]. Science. 1957 May 10;125(3254):936–937. doi: 10.1126/science.125.3254.936-a. [DOI] [PubMed] [Google Scholar]
  24. TOMKINS G. M., SHEPPARD H., CHAIKOFF I. L. Cholesterol synthesis by liver. IV. Suppression by steroid administration. J Biol Chem. 1953 Aug;203(2):781–786. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES